Everest Organics
EVERESTOBSE

Everest Organics

₹312.055.90 (1.93%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
295.00
Today’s high
314.85
52 week low
197.00
52 week high
536.40
Open price
307.00
Previous close
306.15
Live volume
1,439
Lower circuit
249.65
Upper circuit
374.45

Fundamentals

Market Cap
₹303Cr
ROE
7.35%
P/E Ratio(TTM)
54.65
EPS(TTM)
5.71
P/B Ratio
4.01
Dividend Yield
0.00%
Industry P/E
47.87
Book Value
77.73
Debt to Equity
0.66
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹48.91
+14.17%
Profit (Cr)
₹2.63
+630.56%
015304560
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+19%
3Y CAGR-7.0%
Profit growthValue
1Y (TTM)-10%

About

Everest Organics Limited has been engaged in manufacturing Active Pharmaceutical Ingredients and Intermediates for the chemical and pharma industries for approximately three decades. The company's primary mission is to deliver high-quality APIs and intermediates that support the global healthcare ecosystem and make a meaningful industry impact. It remains deeply committed to sustainability and corporate responsibility by minimizing its environmental footprint and upholding high ethical standards in all business aspects. A key part of its strategy involves investing in state-of-the-art technology and upgrading facilities to improve its manufacturing processes for a competitive edge. The company's research and development efforts are focused not just on staying competitive but also on contributing to the advancement of healthcare itself. Demonstrating strong performance, the company registered a total revenue of ₹19,812.74 Lakhs, marking an increase over the previous corresponding year.;
CEO/MD
Dr. Srikakarlapudi Sirisha
Founded in
1993
BSE symbol
524790

Shareholding Pattern

Jun '26
Mar '26
Dec '25
Sep '25
Jun '25
Promoters
60.99%
Retail And Others
38.98%
Other Domestic Institutions
0.02%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹889.85
+7.80 (0.88%)
L
    H
    22,042.7837.054.33
    PfizerPFIZER
    ₹4,731.40
    +141.30 (3.08%)
    L
      H
      21,632.0429.945.15
      ₹8,117.50
      +3.00 (0.04%)
      L
        H
        20,309.63108.323.27
        ₹1,431.20
        +1.20 (0.08%)
        L
          H
          19,798.7130.575.07
          2026
          29
          May
          Quarterly & Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          5
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks